pentobarbital will lower the extent or outcome of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Use of other therapies is strongly encouraged when linagliptin is always to be administered with a CYP3A4 inducerpentobarbital will lower the level or effect of tolterodine by influencing hepatic/intestinal en… Read More